BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Arbutus Announces Closing of $50 Million First Tranche of $116.4 Million Strategic Investment From Roivant Sciences

  Arbutus Biopharma and Roivant Sciences announced the closing of the issue and sale of 500,000 convertible series A preferred shares by Arbutus to Roivant for gross proceeds to Arbutus of US$50 million (Tranche 1).

  October 16, 2017

   · 

  8 min read
• Business

  AzurRx Announces Addition of Dr. Vern Lee Schramm to the Board of Directors

  AzurRx BioPharma announced the appointment of Dr. Vern Lee Schramm to the Board of Directors effective October 10, 2017.

  October 16, 2017

   · 

  3 min read
• Business

  Iradimed to Hold 2017 Third Quarter Financial Results Conference Call on October 30th

  Iradimed will release its 2017 third quarter financial results before the market opens on Monday, October 30th.

  October 16, 2017

   · 

  3 min read
• Business

  Poxel Announces Third Quarter 2017 Financial Update

  POXEL SA, a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes, announced today its cash position for the third quarter of 2017.

  October 16, 2017

   · 

  3 min read
• Business

  Silicon Therapeutics Appoints Dr. Christopher Winter As Chief Of R&D

  Silicon Therapeutics announced today the appointment of Dr. Christopher Winter as Chief of R&D. Dr. Winter joins Silicon Therapeutics from Sanofi.

  October 16, 2017

   · 

  3 min read
• Drug Development

  Kura Oncology Announces Late-Breaking Presentations for Tipifarnib in HRAS Mutant Squamous Head and Neck Cancer and for KO-539 in AML at Upcoming AACR-NCI-EORTC International Conference

  A late-breaking poster will be presented on Saturday, October 28, 2017.

  October 16, 2017

   · 

  4 min read
• Drug Development

  TG Therapeutics Recaps Clinical Data Presentations at the Upcoming 7th Joint ECTRIMS - ACTRIMS Meeting

  TG announced that clinical abstracts featuring data from the Phase II multicenter trial of TG-1101 have been selected for presentation at an upcoming conference.

  October 16, 2017

   · 

  6 min read
• Business

  Cutera Joined By Six Top Physicians for First Medical Advisory Board Meeting

  Cutera announces their 2017 Medical Advisory Board members.

  October 16, 2017

   · 

  2 min read
• Biotech Bay

  Five Prime Announces Cabiralizumab Phase 1a/1b Data Abstract Selected For Late Breaking Oral Presentation At The Society For Immunotherapy Of Cancer (SITC) 32nd Annual Meeting

  Five Prime Therapeutics today announced that the abstract featuring data from the Phase 1a/1b clinical trial evaluating the immunotherapy combination of its CSF-1R antibody, cabiralizumab (FPA008), with Opdivo® (nivolumab), Bristol-Myers Squibb’s PD-1 immune checkpoint inhibitor.

  October 16, 2017

   · 

  2 min read
• Drug Development

  ZIOPHARM Oncology Announces First Patient Dosed in New Phase I Study of Ad-RTS-hIL-12 plus Veledimex for the Treatment of Pediatric Brain Tumors

  ZIOPHARM announced that the first patient has been dosed in a new Phase 1 study of Ad-RTS-hIL-12 with veledimex for the treatment of pediatric brain tumors.

  October 16, 2017

   · 

  7 min read